Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

Researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind to ...

Newer therapies based on the pathophysiologic mechanisms underlying the development ... microchimerism has recently been investigated in autoimmune diseases, including scleroderma, thyroiditis ...

A recent study reveals that age plays a significant role in the outcomes of intermittent fasting. Researchers from Technical University of Munich ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...